In a recent Modern Healthcare article, “7 Due Diligence Issues to Avoid False Claims Act Lawsuits,” Mike Cole Managing Director and Healthcare Industry Leader of Alvarez & Marsal’s Global Transaction Advisory Group, discusses the importance of due diligence with private equity firms.
To avoid being the target of False Claims Act lawsuits, attorneys say private equity firms ought to make sure their companies are on the up and up prior to investing in them. That means extensive due diligence, often by third party companies that specialize in the specific sector of healthcare the target company operates in.
Read the full article here.
Alvarez & Marsal’s Global Transaction Advisory Group Appoints Capital Markets Accounting Advisory Leader for Australia
March 31, 2026
New Managing Director Jenny Arrand to lead firm’s CMAA capabilities in the market, enhancing its globally integrated, end-to-end advisory offering
The Evolution of Private Equity: Performance, Persistence and the Path Ahead with Steven Kaplan
March 2, 2026
Anthony Consoli and Steven Kaplan discuss the early foundations of private equity.
2025 in Review, 2026 in Focus: The Next Cycle for Private Equity and M&A
January 29, 2026
Anthony Consoli and Peter Massumi discuss the fast-changing dynamics of today’s middle-market deal environment.
Alvarez & Marsal's Global Transaction Advisory Group's Canadian Practice Bolsters Industry Expertise to Drive Energy & Infrastructure Growth
January 29, 2026
Alvarez & Marsal (“A&M”), a leading global professional services firm, today announced that Geoff Hayes has joined its Global Transaction Advisory Group (Global TAG) as a Managing Director.
